Literature DB >> 15804776

Ocular tuberculosis in acquired immune deficiency syndrome (AIDS).

Salil Mehta1, Ishwarprasad S Gilada.   

Abstract

AIM: To determine the prevalence and clinical features of ocular tuberculosis in patients with the acquired immune deficiency syndrome (AIDS).
DESIGN: Prospective cross-sectional study.
METHODS: Detailed history and ocular examination of 46 patients (92 eyes) in the outpatient department of an AIDS clinic.
RESULTS: Seventeen of 46 (36.9%) patients had clinical and radiological evidence of pulmonary tuberculosis. Of these, four (23.5%) showed findings consistent with ocular tuberculosis. Lesions included tubercles (1 eye of 3 patients) and chorioretinitis (1 eye of 1 patient). Commonly, these patients had evidence of abdominal tuberculosis. Hemorrhages, cotton-wool spots, herpes zoster ophthalmicus (HZO), cytomegalovirus retinitis (CMVR), and disc edema were other non-tubercular AIDS-related lesions and were seen in seven of the remaining 42 patients (16.2%).
CONCLUSION: Ocular tuberculosis was a common finding in this study and was found in profoundly immunocompromised patients with disseminated tuberculosis. Diagnosis of ocular tuberculosis may help reduce HIV/tuberculosis co-infection mortality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804776     DOI: 10.1080/09273940490518702

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  2 in total

1.  Treatment of neuro-ophthalmologic manifestations of tuberculosis.

Authors:  Susannah Mistr; Pamela S Chavis
Journal:  Curr Treat Options Neurol       Date:  2006-01       Impact factor: 3.972

2.  Ocular inflammatory disease and ocular tuberculosis in a cohort of patients co-infected with HIV and multidrug-resistant tuberculosis in Mumbai, India: a cross-sectional study.

Authors:  Salil Mehta; Homa Mansoor; Samsuddin Khan; Peter Saranchuk; Petros Isaakidis
Journal:  BMC Infect Dis       Date:  2013-05-20       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.